New and Exploratory Therapeutic Agents for AsthmaCRC Press, 12 nov 1999 - 528 páginas Discusses three major classes of asthma therapies-bronchodilators, antiinflammatories, and antiallergics-as well as potential new therapeutic approaches! This comprehensive volume addresses the latest treatment strategies for asthma, keying in on the genetics and molecular biology of asthma and pointing the way toward new, commercially viable therapies. Presents the most up-to-date information available on the genetics, epidemiology, pathology, pharmacology, and pulmonology of asthma. Written by more than 20 leading international experts, New and Exploratory Therapeutic Agents for Asthma Containing over 2000 bibliographic citations and a concise introduction for each chapter, New and Exploratory Therapeutic Agents for Asthma is indispensable for pulmonologists, pediatricians, physiologists, immunologists, allergists, pharmaceutical industry scientists, primary care physicians, and medical school students in these disciplines. |
Índice
1 Epidemiology of Asthma | 1 |
2 Pathophysiology of Asthma | 26 |
3 Pathology of Asthma | 54 |
4 Muscarinic Receptor Subtypes and Anticholinergic Therapy | 78 |
5 LongActing β2Agonist Drugs | 110 |
6 Inhaled Glucocorticoids Established and New | 145 |
7 PlateletActivating Factor Antagonists in Bronchial Asthma | 170 |
8 Tachykinin Receptor Antagonists | 188 |
10 Therapeutic Potential of Phosphodiesterase Type 4 Inhibitors in the Treatment of Asthma | 200 |
11 The AntiIgE Treatment Strategy for Asthma | 286 |
12 Activity of TCell Subsets in Allergic Asthma | 299 |
13 New Targets for Future Asthma Therapy | 316 |
14 Current Practice and Future Trends in Clinical Trials in Asthma | 345 |
Author Index | 357 |
474 | |
Otras ediciones - Ver todo
New and Exploratory Therapeutic Agents for Asthma Michael Yeadon,Zuzana Diamant Vista previa restringida - 1999 |
New and Exploratory Therapeutic Agents for Asthma Michael Yeadon, PH.D.,Zuzana Diamant, M.D., PH.D. No hay ninguna vista previa disponible - 2019 |
New and Exploratory Therapeutic Agents for Asthma Michael Yeadon,Zuzana Diamant No hay ninguna vista previa disponible - 1999 |
Términos y frases comunes
activity addition agonists airway hyperresponsiveness airway responsiveness airway smooth muscle allergen Allergy antibody antigen associated asthma asthmatic patients atopic Barnes PJ binding blocked bronchial bronchoconstriction bronchodilator cAMP cause challenge changes chronic clinical compared corticosteroids cytokines decrease demonstrated disease dose drugs edited effects eosinophils evidence expression factor fenoterol formoterol function gene guinea pigs histamine human important improvement increased induced inflammation inflammatory inhaled inhibition inhibitors involved leukotriene levels lung M2 receptors major mast cells measures mechanisms mediated methacholine muscarinic receptors nerves normal obstruction oral patients PDE4 Pharmacol phosphodiesterase Physiol potent prevent production protein pulmonary recently receptor antagonist reduced regulation release reported Respir Crit respiratory response Rev Respir role rolipram salmeterol secretion selective sensitive severe shown significant specific stimulation studies subjects suggest suppression symptoms systemic tachykinin therapy tissue trachea treatment vivo